header image
 

Welcome to Missions of Health!

Welcome!

Missions of Health is a nonprofit organization bringing health and well-being to the most underserved people and areas of our world.

Missions of Health was founded with the goal to combat poverty and disease while holistically developing communities. After years of partnering with medical officials in Pallisa, Uganda, Missions of Health aims to inspire and equip a generation, while creating a global standard of health and well-being. Currently, Missions of Health is actively focused on malaria and the nearly 500 Million people who contract it every year. We believe with small voices, united in chorus we can end the deadliest disease of all time.

Kony 2012

KONY 2012 IS A FILM AND CAMPAIGN BY INVISIBLE CHILDREN THAT AIMS TO MAKE JOSEPH KONY FAMOUS, NOT TO CELEBRATE HIM, BUT TO RAISE SUPPORT FOR HIS ARREST AND SET A PRECEDENT FOR INTERNATIONAL JUSTICE.

HIGHLIGHT: Bite Back

Highlighting another great campaign this week, Bite Back, was started by Compassion International and is devoted to ending one of the deadliest diseases of all time, malaria.  We deeply believe in their cause and fight and encourage you to watch the above video and support their campaign!

Famine. War. Drought. (FWD)

With the recent crisis in the Horn of Africa, many are teaming up in whatever way they can to provide support and aid, including the NFL and the United States State Department. The State Department has recently created FWD: We Are The Relief to help inspire action that ends the famine affecting 13 million people in East Africa. Ten different players from teams around the NFL have joined the State Departments campaign that encourages people to FWD (forward) information about the devastating famine.

Players from around the NFL include Ray Lewis, linebacker for the Baltimore Ravens, Asante Samuel, cornerback for the Philadelphia Eagles, Nnamdi Asomugha, cornerback for the Philadelphia Eagles, Naurice Jones-Drew, runningback for the Jacksonville Jaguars, Greg Jennings, wide receiver for the Green Bay Packers, Larry Fitzgerald, wide receiver for the Arizona Cardinals, Josh Freeman, quarterback for the Tampa Bay Buccaneers, Lamarr Woodley, linebacker for the Pittsburgh Steelers, Matt Forte, halfback for the Chicago Bears and Jeff Saturday, center for the Indianapolis Colts.

To donate $10 text ‘GIVE’ to 777444 or visit http://action.usaid.gov for more information.


KONY 2012

www.invisiblechildren.com

Interview: Dr. Lusingu Malaria Vaccine in Tanzania (via ONE.org)

After speaking with Dr. Loucq about the exciting development of the malaria vaccine through thePATH Malaria Vaccine Initiative (MVI), we were thrilled to talk to Dr. John Lusingu, a malaria vaccine researcher at an MVI trial site in Tanzania. Dr. Lusingu discussed the devastating impact of malaria in his community and ongoing research on the ground.

image004John outside of the newly built state of the art research facility

 

How has malaria impacted your community?
Malaria’s devastating impact on my community’s children and their families is readily apparent, despite reports that malaria incidence is declining globally. Every single day, children and pregnant women are brought to our local clinics with this terrible disease, and many die from its effects. Beyond malaria’s medical impact, families are affected economically –- even despite free medical treatment for under-fives -– largely due to high transportation costs and lost productivity when sick children require care. Children lucky enough to survive severe malaria often have mental impairments that prevent them from attending school. Older children are also often forced to stay home from school to take care of their sick brothers or sisters so their parents can go work on the farms, especially during farming season.

image002

What is the focus of your research at the trial site in Tanzania?
In Korogwe, I lead a team of investigators who are participating in the multi-center Phase 3 RTS,S malaria vaccine candidate trial across seven countries in Africa. The malaria vaccine candidate has been produced by GlaxoSmithKline Biologicals and supported by the PATH Malaria Vaccine Initiative and the Bill & Melinda Gates Foundation. We hope that a malaria vaccine will complement existing tools to control malaria in sub-Saharan Africa, including bed nets, indoor residual spraying and treatment with artemisinin based combination therapies. The malaria vaccine candidate, once licensed and made available, could be included in standard immunization programs in malaria-endemic regions of Africa and help save countless lives.

image005John showing a malaria diagnostic test done on the infant pictured just moments before

How did you get involved in malaria research?
When I was young, I would often go to the farms in the lowland communities near Mt. Kilimanjaro in Tanzania with my parents during rainy season. I would always head back to the mountains at night for fear of being bitten by mosquitoes, which I knew could lead to a disease known as itheng’u by the Pare tribe (translated into malaria). As a result, I never suffered from malaria until the age of 16, when I went to secondary school in the lowland community of Moshi. I had repeated episodes for almost 10 years after my initial infection, after which I did not suffer from malaria for many years. I wondered why this had happened. In my postgraduate medical studies, I researched how to mimic the natural immunity to malaria I had developed and studied whether it could be applied to children. Children born in malaria-endemic communities do not have complete immunity to malaria. But if we can put something in their bodies that can boost their immunity when they are young and most vulnerable to malaria –- like a vaccine –- we can help prevent them from contracting and even dying from the disease.

image001
John examining a patient in the pediatric ward of Korogwe District Hospital

How will this research help improve the livelihood of people in your community?
Once licensed and deployed, the malaria vaccine candidate could complement existing interventions and begin protecting children from malaria and saving lives, which could have a tremendous impact on my community. Children will be able to go to school and parents to work, dramatically reducing the social and economic burdens of the disease.

In the meantime, though, we have also benefited significantly from massive investments in training and infrastructure in the communities where the clinical trial is being conducted. In Korogwe, teams of staff have been trained to conduct trials according to international standards. A fully-equipped modern laboratory that specializes in parasitology, hematology, biochemistry and microbiology has been built and is now fully functioning. Our vaccine ‘cold chain,’ X-ray services, pediatric care, and referral systems have all been enhanced. Important health services are also provided to both participants and non-participants in the trial, and community members’ compliance with treatment and attitudes toward health-seeking behavior have improved.

What message would you like to share with ONE members on World Malaria Day?
Let us join our efforts to help ensure that a malaria vaccine is added to our current arsenal of malaria interventions. A vaccine could complement our existing tools and help further prevent Africa’s children from needlessly dying from this terrible disease.

Dr. John Lusingu, MD, Ph.D is a Principal Research Scientist at the National Institute for Medical Research (NIMR) in Tanzania and a postdoctoral fellow of the University of Copenhagen, Denmark. He is a Principal Investigator for the RTS,S Phase 3 malaria vaccine candidate trial in Korogwe, Tanzania.

Photo credit: John Michael Maas/ Darby Communications

This article originally appeared at ONE.org, who holds all copyright.

Impatient Optimists

Since his days at Microsoft, Bill Gates has been an amazing supporter of philanthropic causes and efforts.  One of the his main focuses has been malaria and gives a great expounding of the disease and the efforts to eradicate it from the globe.

Progress Against Malaria

Tremendous work has been made in the fight against malaria and its important to celebrate these accomplishments as we progress. To do this, the Bill & Melinda Gates Foundation has released an amazing infographic displaying and highlighting the amazing life saving work taking place all around the world. Learn about important interventions and regions where lives are being saved everyday!

We Can End Malaria

Poor Economics: Rethinking the Way to Fight Poverty

Using data to rethink the ways we fight global poverty isn’t necessarily a new concept. The debate of effective charity has been around for decades even though, data is used to track investments and returns in nearly every area of society, from government to finance to athletics, it has been difficult to make sense of data in the philenthropic world, to discover what kind of charity is actually working.  This has often lead to ineffective charity and causing more harm than good in communities in the developing world.  Its a probably that many have known existed but few have holistically figured out how to solve.  Well, two MIT economists, Abhijit V. Banerjee and Esther Duflo have authored and introduced a new book entitled Poor Economics: A Radical Rethinking of the Way to Fight Global Poverty.

The book mainly focuses of the difficulities and results for effective charity and aid, while introducing concepts of what they call, isolated and specialized aid.  This type of aid, is the type that can often have a higher impact on specific communities and ensure greater returns of success.  Recently, Bill Gates has been one of the largest advocates of data and researched based aid, and wrote a worthy review of Poor Economics, which is below.

As I prepare for the G20 summit, I firmly believe that data has to be at the core of the analysis and conclusions in our report on development. At the same time, we need to look beyond the numbers and understand the everyday challenges faced by the world’s poorest people. The book Poor Economics is very helpful, because it is both empirically rigorous and insightful about the realities that the data doesn’t always capture.

Poor Economics is by two MIT economists, Abhijit Vinayak Banerjee and Esther Duflo.  Their life’s work is traveling to poor countries, looking closely at what works and what doesn’t work in efforts to fight hunger and disease, improve education, and broaden access to basic financial services. The authors are directors of J-PAL, an MIT poverty action lab that’s a network of 59 professors around the world who use scientific methods to answer critical questions about alleviating poverty.

To me, what’s really great about J-PAL is that it’s producing scientific evidence that can help make our anti-poverty efforts more effective. This is tremendously important. The money that governments invest in development is saving millions of lives, and improving hundreds of millions. But to sustain support for these efforts, we need to rigorously assess the cost-effectiveness and overall impact of aid, and make continuous improvements.

J-PAL conducts randomized evaluations of different approaches to achieving a particular objective, such as reducing malnutrition. For example, researchers try different ways of distributing food aid in similar villages, observe what happens, and compare the results. They’ve repeatedly found that outside of situations where there’s actual famine, just handing out food – no matter how nutritious – doesn’t necessarily improve nutrition. Sometimes people just cut back on their own food purchases and use that money for something else they need or want, even though consuming more calories could increase their productivity.

Although this may seem strange to us, J-PAL probes deeper to find out why people do what they do. In some instances, they may be in a situation where consuming more calories to work harder will not raise their incomes much or at all. And they may have other, urgent expenses, such as for health care.

Poor Economics does a great job of bringing alive the complexities of poor people’s lives. It explores the tough, difficult decisions they must make – often based on very little information and with no room for error – about things that most of us take for granted, like access to enough food, clean water or vaccinations.

Poor Economics focuses on the specific results and unintended consequences of anti-poverty projects, and in doing so, it reveals some smart strategies for achieving positive results. In some situations, for instance, limited aid may go farther if it is directed toward specific groups of people. One example mentioned in the book is delivering food aid and nutrition information to pregnant women and to children whose development can be permanently stunted by malnutrition.

Related to food aid, one of the “win-win” strategies we’re using at the foundation is helping poor farmers sell their produce to aid programs in their own and neighboring countries. That way, the aid programs can fight hunger and help raise the incomes of local farmers at the same time.

Poor Economics also is very good in spotlighting how small tweaks can sometimes turn failing interventions into effective ones. As I’ve learned, this often involves identifying and removing unintended barriers that prevent people from getting vaccinated, say, or using bed nets to prevent malaria. Given the challenges that poor people face in their daily lives, we need to make it as easy as possible for them to get the help they need.

For example, Rajasthan, India, had for a long time suffered from very low immunization rates – about 6%. This despite the government’s providing the vaccines for free. Increasing the vaccination rate was a challenge – walking to the clinics can be a hassle, and the clinics are unpredictably closed. To address these barriers, mobile clinics were established to provide vaccines on site. The impact of these mobile clinics was profound, with full vaccination rates jumping from 6% to more than 18%. Building on this success, the program was further enhanced with an incentive: a bag of lentils to all families vaccinated, which effectively doubled the rate again to 38%. Even with the incentive, the program was twice as cost effective per patient as just the mobile clinics alone, since the clinic staff was much busier. More importantly, a much larger group of children was vaccinated against polio, measles, DPT and tuberculosis – saving families from potential tragedy down the road and government from higher costs of sick care. You can read the J-PAL policy briefcase “Incentives for Immunization” to learn more about this study.

To be more effective, we also need a deeper understanding of people’s values and cultures. I’ve seen first-hand that local knowledge is critical. A couple of years ago, I visited AIDS-prevention projects that our foundation has supported in South Africa. They were effectively reducing AIDS transmission from women to men by persuading adult and teenaged men to be circumcised. As you can imagine, this was not an easy task, but with knowledge and respect, it can be done, and it can save many lives.

With the authors’ experience on the ground and their willingness to go where the evidence leads, I found Poor Economics a refreshing change from the sometimes theoretical and divisive debates that surround development aid. (An excellent companion book I’d also recommend is Getting Better: Why Global Development is Succeeding.)

So, is development aid good or bad? A moral obligation or a waste of money? That depends on how it’s done, say Banerjee and Duflo. Financial resources are finite, so let’s figure out how to use them in ways that can have the most substantial impact.

Excerpts of this post originally appeared on The Gates Notes

[BREAKING] – Obama Sends Troops to Uganda

Two days ago President Obama authorized the deployment to Uganda of approximately 100 combat-equipped U.S. forces to help regional forces “remove from the battlefield” – meaning capture or kill – Lord’s Resistance Army leader Joseph Kony and senior leaders of the LRA.

The forces will deploy beginning with a small group and grow over the next month to 100. They will ultimately go to Uganda, South Sudan, the Central African Republic, and the Democratic Republic of the Congo, with the permission of those countries.

The president made this announcement in a letter to House Speaker John Boehner, R-Ohio, Friday afternoon, saying that “deploying these U.S. Armed Forces furthers U.S. national security interests and foreign policy and will be a significant contribution toward counter-LRA efforts in central Africa.”

He said that “although the U.S. forces are combat-equipped, they will only be providing information, advice, and assistance to partner nation forces, and they will not themselves engage LRA forces unless necessary for self-defense.”

The president said that for more than two decades the LRA has been responsible for having “murdered, raped, and kidnapped tens of thousands of men, women, and children in central Africa” and continues to “commit atrocities across the Central African Republic, the Democratic Republic of the Congo, and South Sudan that have a disproportionate impact on regional security.”

A senior Defense official says the 100 military personnel will be mostly Special Operations Forces and that they “will be traveling out to field locations in the areas affected by the LRA where they can interact with and advise those forces that are actively pursuing the LRA.” The official stressed, “they will not be engaging in direct combat against the LRA.”

The US has been helping the four African nations counter the LRA for several years by providing local militaries with training and equipment. In the Democratic Republic of the Congo the US helped train a light infantry battalion deployed to fight the LAR and over the last three years in Uganda the US has provided $33 million to help Uganda’s military.

As for how long the US troops will be in the region, a spokesman at US Africa Command says he could not provide specifics, “but our forces are prepared to stay as long as necessary to enable regional security forces to carry on independently.

The president in his letter noted that Congress passed “the Lord’s Resistance Army Disarmament and Northern Uganda Recovery Act,” signed into law on May 24, 2010, in which, the president said, “the Congress also expressed support for increased, comprehensive U.S. efforts to help mitigate and eliminate the threat posed by the LRA to civilians and regional stability.”

When the president signed that letter in May 2010, he said the bill “crystallizes the commitment of the United States to help bring an end to the brutality and destruction that have been a hallmark of the LRA across several countries for two decades, and to pursue a future of greater security and hope for the people of central Africa. The Lord’s Resistance Army preys on civilians – killing, raping, and mutilating the people of central Africa; stealing and brutalizing their children; and displacing hundreds of thousands of people. Its leadership, indicted by the International Criminal Court for crimes against humanity, has no agenda and no purpose other than its own survival. It fills its ranks of fighters with the young boys and girls it abducts. By any measure, its actions are an affront to human dignity.”

The act passed both houses of Congress with overwhelming support on May 10, 2010 with language that included “providing political, economic, military, and intelligence support for viable multilateral efforts to protect civilians from the Lord’s Resistance Army.”

This article originally appeared at ABCNEWS.com and reserves all copyright and permission.

 
WP Like Button Plugin by Free WordPress Templates